International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels

Pharmacological Reviews

Volumn 57, Issue 4, 2005, Pages 411-425

  Catterall, William A ^a   Perez Reyes, Edward ^b   Snutch, Terrance P ^c   Striessnig, Joerg ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; 7 [[4 [BIS(4 FLUOROPHENYL)METHYL] 1 PIPERAZINYL]METHYL] 2 [(2 HYDROXYETHYL)AMINO] 4 ISOPROPYL 2,4,6 CYCLOHEPTATRIEN 1 ONE; AMILORIDE; ANTIDEPRESSANT AGENT; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DEVAPAMIL; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; GABAPENTIN; INHALATION ANESTHETIC AGENT; ISRADIPINE; MIBEFRADIL; NIFEDIPINE; NIMODIPINE; OMEGA AGATOXIN IVA; OMEGA AGATOXIN VIA; PENFLURIDOL; PHENYLALKYLAMINE; PIMOZIDE; PIPERIDINE DERIVATIVE; PROTEIN SUBUNIT; SNX 482; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL;

ACTION POTENTIAL; CALCIUM CURRENT; GENE EXPRESSION; HUMAN; NEUROTRANSMISSION; NOMENCLATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION; VOLTAGE CLAMP;

ANIMALS; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM SIGNALING; ELECTROPHYSIOLOGY; HUMANS; ION CHANNEL GATING; STRUCTURE-ACTIVITY RELATIONSHIP; TERMINOLOGY;

EID: 29844439240     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.57.4.5     Document Type: Review

References (13)

1. Birnbaumer L, Campbell KP, Catterall WA, Harpold MM, Hofmann F, Horne WA, Mori Y, Schwartz A, Snutch TP, Tanabe T, et al. (1994) The naming of voltagegated calcium channels. Neuron 13:05-506.
2. 2+ channels. Annu Rev Cell Dev Biol 16:521-555.
3. Chandy KG and Gutman GA (1993) Nomenclature for mammalian potassium channel genes. Trends Pharmacol Sci 14:434.
4. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A, Snutch TP, Tanabe T, Birnbaumer L, et al. (2000) Nomenclature of voltagegated calcium channels Neuron 25:533-535.
5. Glossmann H and Striessnig J (1990) Molecular properties of calcium channels Rev Physiol Biochem Pharmacol 114:1-105.
6. Hockerman GH, Peterson BZ, Johnson BD, and Catterall WA (1997) Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 37:361-396.
7. 2+ channel diversity. Annu Rev Neurosci 17:399-418.
8. Hofmann F, Lacinová L, and Klugbauer N (1999) Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol 139:33-87.
9. Miljanich GP and Ramachandran J (1995) Antagonists of neuronal calcium channels: structure, function and therapeutic implications. Annu Rev Pharmacol Toxicol 35:707-734.
10. Perez-Reyes E (2003) Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 83:117-161.
11. Striessnig J (1999) Pharmacology, structure and function of cardiac L-type calcium channels. Cell Physiol Biochem 9:42-269.
12. Tsien RW, Lipscombe D, Madison D, Bley K, and Fox A (1995) Reflections on calcium channel diversity, 1988-1994. Trends Neurosci 18:52-54.
13. Yu FH and Catterall WA (2004) The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Sci STKE. 253:re15.